7Baggers

Avanos Medical Quarterly Balance Sheets Chart

Quarterly
 | 
Annual
 
 Goodwill  
 Account Receivables  
 Cash and Cash Eq  
 Long-Term Debt  
 Inventory  
20200930 20201231 20210331 20210630 20210930 20211231 20220331 20220630 20220930 20221231 20230331 20230630 20230930 20231231 20240331 20240630 20240930 20241231 20250331 20250630 0118236354472590708826Milllion

Avanos Medical Quarterly Balance Sheets Table

Quarterly
 | 
Annual
 
Unit: USD2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 
                                              
  assets                                            
  current assets                                            
  cash and cash equivalents90,300,000 97,000,000 107,700,000 89,000,000 92,200,000 75,800,000 87,700,000 107,100,000 81,800,000 95,700,000 127,700,000 117,000,000 106,500,000 104,300,000 118,500,000 97,800,000 99,900,000 100,100,000 111,500,000 180,000,000 185,000,000 187,700,000 205,300,000 214,400,000 288,100,000 348,300,000 384,500,000 411,800,000 479,600,000 203,100,000 219,700,000 166,100,000 154,800,000 143,100,000 113,700,000 86,700,000 79,200,000 165,100,000 129,500,000 112,500,000 114,300,000 166,200,000 149,000,000 58,400,000 
  accounts receivable110,200,000 104,800,000 132,800,000 131,900,000 123,000,000 131,300,000 142,800,000 145,200,000 152,300,000 142,700,000 167,900,000 146,200,000 145,400,000 161,600,000 118,200,000 117,500,000 106,700,000 105,300,000 108,600,000 182,300,000 137,800,000 159,600,000 163,800,000 157,700,000 124,300,000 135,000,000 150,500,000 151,800,000 189,200,000 199,500,000 203,000,000 194,400,000 184,100,000 181,200,000 190,100,000 189,100,000 195,200,000 206,300,000 224,700,000 204,400,000 200,100,000 226,500,000 233,900,000 192,200,000 
  inventories142,700,000 138,100,000 138,800,000 161,900,000 163,900,000 165,600,000 163,200,000 156,600,000 148,300,000 200,000,000 190,300,000 193,600,000 169,000,000 157,600,000 150,300,000 158,400,000 159,700,000 165,200,000 168,900,000 184,100,000 174,100,000 153,100,000 145,900,000 144,500,000 133,900,000 129,600,000 121,400,000 121,200,000 107,800,000 92,300,000 91,100,000 300,500,000 296,200,000 273,400,000 272,500,000 298,700,000 310,300,000 308,400,000 303,200,000 323,600,000 323,900,000 293,000,000 283,100,000 294,700,000 
  prepaid and other current assets12,800,000 12,500,000 14,100,000 15,900,000 22,300,000 28,600,000 28,800,000 13,600,000 15,800,000 15,400,000 13,900,000 13,200,000 16,200,000 15,700,000 18,600,000    18,900,000    23,500,000    57,200,000    14,400,000    17,200,000    18,600,000    16,800,000  
  total current assets356,000,000 352,400,000 393,400,000 472,600,000 474,100,000 467,800,000 487,000,000 524,600,000 506,900,000 453,800,000 499,800,000 470,000,000 437,100,000 439,200,000 418,600,000 405,000,000 443,500,000 447,900,000 467,200,000 567,600,000 517,100,000 524,100,000 538,500,000 546,500,000 572,500,000 660,000,000 713,600,000 737,200,000 876,500,000 1,161,100,000 1,160,700,000 681,000,000 654,800,000 614,400,000 593,500,000 605,600,000 609,700,000 706,600,000 676,000,000 666,000,000 653,100,000 703,100,000 684,900,000 596,100,000 
  property, plant and equipment114,300,000 109,800,000 110,700,000 109,500,000 110,700,000 116,200,000 117,200,000 116,800,000 122,600,000 163,500,000 163,900,000 163,400,000 164,300,000 166,900,000 168,100,000 169,700,000 171,900,000 173,400,000 175,300,000 177,300,000 179,300,000 178,700,000 184,500,000 182,100,000 174,400,000 159,600,000 154,100,000 137,000,000 123,500,000 117,500,000 109,900,000 261,100,000 259,700,000 258,300,000 260,800,000 265,000,000 272,600,000 275,600,000 279,500,000 282,100,000 286,000,000 281,800,000 277,800,000 292,800,000 
  operating lease right-of-use assets31,100,000 32,100,000 34,100,000 26,500,000 29,400,000 24,200,000 26,800,000 27,100,000 29,100,000 28,300,000 30,600,000 32,500,000 33,900,000 36,100,000 38,600,000 41,400,000 42,900,000 45,100,000  56,500,000 60,000,000 59,900,000  64,000,000 67,200,000 54,900,000                   
  goodwill381,200,000 455,900,000 455,600,000 795,100,000 794,400,000 794,900,000 796,100,000 791,500,000 762,600,000 821,500,000 819,400,000 823,600,000 825,000,000 826,000,000 801,600,000 801,800,000 802,600,000 802,100,000 802,500,000 801,200,000 800,200,000 799,800,000 800,900,000 800,500,000 782,300,000 783,700,000 783,600,000 786,700,000 763,800,000 764,600,000 764,700,000 1,032,000,000 1,030,900,000 1,029,700,000 1,029,000,000 1,031,900,000 1,031,600,000 946,800,000 945,200,000 943,400,000 1,422,800,000 1,422,100,000 1,426,100,000 1,429,000,000 
  other intangible assets105,400,000 107,200,000 112,300,000 220,100,000 226,200,000 232,800,000 239,500,000 242,200,000 222,600,000 244,700,000 251,000,000 258,700,000 264,900,000 271,100,000 141,200,000 145,300,000 149,500,000 153,600,000 157,700,000 170,100,000 174,600,000 179,300,000 184,300,000 189,500,000 158,500,000 163,200,000 168,200,000 173,900,000 139,500,000 144,600,000 148,900,000 154,800,000 159,800,000 164,400,000 169,800,000 176,700,000 182,400,000 77,400,000 82,600,000 89,000,000 95,400,000 101,800,000 108,300,000 116,300,000 
  deferred tax assets25,300,000 25,000,000 24,900,000 6,600,000 6,300,000 6,300,000 6,500,000 4,300,000 4,400,000 4,500,000 4,600,000 10,900,000 11,100,000 11,300,000 10,000,000 23,600,000 61,900,000 15,400,000 10,000,000 12,000,000 14,000,000 11,000,000 16,100,000 12,300,000 13,300,000 6,200,000 6,300,000 6,300,000 10,600,000 11,300,000 7,600,000 16,300,000 16,100,000 15,800,000 15,100,000 12,200,000 12,000,000 11,300,000 14,900,000      
  other assets25,700,000 25,400,000 23,200,000 25,800,000 16,700,000 19,100,000 19,300,000 18,400,000 18,500,000 18,600,000 17,600,000 16,100,000 16,500,000 15,900,000 16,500,000 11,100,000 11,000,000 11,300,000 11,800,000 14,400,000 10,700,000 10,900,000 11,300,000 12,800,000 15,200,000 6,400,000 7,600,000 3,400,000 3,500,000 3,800,000 4,100,000 3,700,000 3,600,000 3,800,000 3,600,000 3,600,000 3,700,000 2,000,000 2,000,000 25,800,000 28,200,000 27,600,000 27,900,000 15,200,000 
  total assets1,039,000,000 1,107,800,000 1,154,200,000 1,656,200,000 1,657,800,000 1,661,300,000 1,692,400,000 1,724,900,000 1,666,700,000 1,734,900,000 1,786,900,000 1,775,200,000 1,752,800,000 1,766,500,000 1,594,600,000 1,597,900,000 1,683,300,000 1,648,800,000 1,672,800,000 1,799,100,000 1,755,900,000 1,763,700,000 1,799,600,000 1,807,700,000 1,783,400,000 1,834,000,000 1,833,400,000 1,844,500,000 1,917,400,000 2,202,900,000 2,195,900,000 2,148,900,000 2,124,900,000 2,086,400,000 2,071,800,000 2,095,000,000 2,112,000,000 2,019,700,000 2,000,200,000 2,006,300,000 2,485,500,000 2,536,400,000 2,527,600,000 2,449,400,000 
  liabilities and stockholders’ equity                                            
  current liabilities                                            
  current portion of long-term debt9,400,000 9,400,000 9,400,000 9,400,000 10,200,000 9,400,000 8,600,000 6,200,000 6,200,000 6,200,000 6,200,000 6,200,000 4,700,000                  39,800,000              
  current portion of operating lease liabilities10,400,000 10,400,000 10,900,000 13,700,000 14,400,000 11,500,000 12,800,000 12,700,000 13,500,000 12,100,000 12,800,000 13,400,000 13,500,000 14,500,000 14,700,000 14,700,000 14,900,000 15,100,000  15,600,000 15,400,000 14,300,000  14,500,000 14,700,000 11,700,000                   
  trade accounts payable48,800,000 46,000,000 54,300,000 54,200,000 51,400,000 57,000,000 56,300,000 52,100,000 65,400,000 59,600,000 67,900,000 62,700,000 64,200,000 63,800,000 56,400,000 54,900,000 65,500,000 59,200,000 67,600,000 75,900,000 75,800,000 73,500,000 83,000,000 94,700,000 99,400,000 148,800,000 169,900,000 159,200,000 176,900,000 194,400,000 171,200,000 172,500,000 184,400,000 179,700,000 173,100,000 166,500,000 168,600,000 181,100,000 163,200,000 179,100,000 200,600,000 192,100,000 168,700,000 118,400,000 
  accrued expenses66,000,000 71,400,000 91,300,000 82,700,000 79,500,000 75,100,000 93,200,000 97,200,000 72,700,000 80,600,000 98,900,000 80,000,000 68,700,000 74,600,000 68,100,000 59,600,000 77,900,000 80,300,000 83,200,000 87,900,000 84,800,000 101,600,000 114,800,000 108,900,000 72,900,000 77,900,000 94,400,000 106,300,000 175,900,000 128,300,000 144,900,000 146,900,000 137,400,000 130,300,000 151,300,000 144,200,000 136,300,000 128,200,000 152,000,000 147,700,000 123,400,000 145,000,000 183,400,000 148,600,000 
  total current liabilities134,600,000 137,200,000 165,900,000 212,900,000 208,200,000 205,200,000 234,600,000 170,700,000 160,500,000 158,500,000 185,800,000 162,300,000 151,100,000 152,900,000 139,200,000 129,200,000 158,300,000 154,600,000 166,300,000 179,400,000 176,000,000 189,400,000 212,500,000 218,100,000 187,000,000 238,400,000 264,300,000 265,500,000 352,800,000 360,600,000 389,800,000 319,400,000 321,800,000 310,000,000 324,400,000 310,700,000 304,900,000 309,300,000 315,200,000 326,800,000 324,000,000 341,000,000 356,000,000 277,900,000 
  long-term debt95,700,000 98,000,000 125,300,000 152,600,000 164,900,000 167,200,000 159,400,000 258,300,000 203,300,000 204,700,000 226,300,000 247,800,000 249,300,000 254,400,000 130,000,000 145,000,000 165,000,000 175,000,000 180,000,000 248,500,000 248,400,000 248,200,000 248,100,000 247,900,000 247,800,000 247,900,000 247,700,000 247,600,000 247,400,000 542,000,000 541,100,000 580,400,000 579,900,000 579,400,000 579,000,000 589,400,000 624,000,000 578,500,000 578,100,000 585,900,000 585,800,000 631,400,000 632,300,000  
  operating lease liabilities21,800,000 23,100,000 24,600,000 26,500,000 28,800,000 26,600,000 28,300,000 29,500,000 30,900,000 32,400,000 34,700,000 36,800,000 38,400,000 40,000,000 42,800,000 46,100,000 47,500,000 50,100,000  56,100,000 58,900,000 58,800,000  62,500,000 65,500,000 57,700,000                   
  deferred tax liabilities6,300,000 5,600,000 5,500,000 23,900,000 23,400,000 23,600,000 23,800,000 28,700,000 21,800,000 25,100,000 25,400,000 37,000,000 34,700,000 34,700,000 9,600,000 5,600,000 5,600,000 5,600,000 5,700,000 13,800,000    500,000 600,000 4,400,000 4,400,000 1,100,000 1,000,000 18,300,000 17,800,000 36,500,000 36,400,000 36,200,000 35,800,000 63,400,000 63,400,000 23,900,000 23,800,000      
  other long-term liabilities4,300,000 4,500,000 4,400,000 10,600,000 10,500,000 10,800,000 10,000,000 15,600,000 15,400,000 15,500,000 23,500,000 27,800,000 27,700,000 28,000,000 9,100,000 10,100,000 10,600,000 10,900,000 11,000,000 11,400,000 11,000,000 10,800,000 11,200,000 11,800,000 5,600,000 5,500,000 19,800,000 30,100,000 29,600,000 30,200,000 31,800,000 31,900,000 30,000,000 29,900,000 30,100,000 30,000,000 30,200,000 28,200,000 27,800,000 52,600,000 53,900,000 52,200,000 48,100,000  
  total liabilities262,700,000 268,400,000 325,700,000 426,500,000 435,800,000 433,400,000 456,100,000 502,800,000 431,900,000 436,200,000 495,700,000 511,700,000 501,200,000 510,000,000 330,700,000 336,000,000 387,000,000 396,200,000 416,300,000 509,200,000 494,300,000 507,200,000 534,400,000 540,800,000 506,500,000 553,900,000 536,200,000 544,300,000 630,800,000 951,100,000 980,500,000 968,200,000 968,100,000 955,500,000 969,300,000 993,500,000 1,022,500,000 939,900,000 944,900,000 965,300,000 963,700,000 1,024,600,000 1,036,400,000 370,400,000 
  commitments and contingencies                                            
  stockholders’ equity                                            
  preferred stock - 0.01 par value - authorized 20,000,000 shares, none issued                                            
  common stock - 0.01 par value - authorized 300,000,000 shares, 46,314,057 outstanding as of june 30, 2025 and 45,962,627 outstanding as of december 31, 2024500,000                                            
  additional paid-in capital1,686,900,000 1,682,800,000 1,678,600,000 1,674,700,000 1,671,500,000 1,667,700,000 1,663,600,000 1,659,700,000 1,654,900,000 1,651,000,000 1,646,400,000 1,642,300,000 1,637,400,000 1,633,300,000 1,628,800,000 1,625,700,000 1,621,300,000 1,617,300,000 1,609,400,000 1,604,100,000 1,599,900,000 1,596,400,000 1,593,900,000 1,592,100,000 1,586,800,000 1,582,500,000 1,578,100,000 1,575,500,000 1,567,700,000 1,557,300,000 1,550,500,000 1,547,400,000 1,543,800,000 1,538,100,000 1,533,200,000 1,530,400,000 1,527,300,000 1,521,700,000 1,518,000,000 1,517,900,000 1,514,300,000 1,507,900,000 1,502,500,000  
  accumulated deficit-777,200,000 -700,400,000 -707,000,000 -309,700,000 -314,000,000 -315,800,000 -314,900,000 -325,400,000 -321,700,000 -253,600,000 -253,100,000 -270,000,000 -293,100,000 -304,500,000 -310,300,000 -320,300,000 -285,200,000 -323,100,000 -315,500,000 -268,300,000 -287,600,000 -284,600,000 -288,300,000 -282,200,000 -270,700,000 -262,700,000 -242,400,000 -240,200,000 -244,400,000 -279,700,000 -299,900,000 -332,700,000 -349,300,000 -366,400,000 -379,200,000 -389,200,000 -398,300,000 -404,800,000       
  treasury stock-101,900,000 -101,200,000 -99,000,000 -98,900,000 -98,500,000 -95,000,000 -85,900,000 -79,700,000 -70,500,000 -67,900,000 -66,800,000 -66,400,000 -55,400,000 -40,700,000 -21,300,000 -10,400,000 -10,300,000 -9,800,000 -9,800,000 -9,300,000 -9,200,000 -8,900,000 -8,900,000 -8,700,000 -8,600,000 -7,200,000 -5,300,000 -5,100,000 -5,100,000 -4,500,000 -4,400,000 -3,900,000 -3,900,000 -1,900,000 -1,900,000 -1,900,000 -1,900,000 -1,000,000 -1,000,000 -1,000,000 -1,000,000    
  accumulated other comprehensive loss-32,000,000 -42,300,000 -44,600,000 -36,900,000 -37,500,000 -29,500,000 -27,000,000 -33,000,000 -28,400,000 -31,300,000 -35,800,000 -42,900,000 -37,800,000 -32,100,000 -33,800,000 -33,600,000 -30,000,000 -32,300,000 -28,100,000 -37,100,000 -42,000,000 -46,900,000 -32,000,000 -34,800,000 -31,100,000 -33,000,000 -33,700,000 -30,500,000 -32,100,000 -21,800,000 -31,300,000 -30,600,000 -34,300,000 -39,400,000 -50,100,000 -38,300,000 -38,100,000 -36,600,000 -43,200,000 -42,800,000 -28,900,000 -25,600,000  -21,100,000 
  total stockholders’ equity776,300,000 839,400,000 828,500,000 1,229,700,000 1,222,000,000 1,227,900,000 1,236,300,000 1,222,100,000 1,234,800,000 1,298,700,000 1,291,200,000 1,263,500,000 1,251,600,000 1,256,500,000 1,263,900,000 1,261,900,000 1,296,300,000 1,252,600,000 1,256,500,000 1,289,900,000 1,261,600,000 1,256,500,000 1,265,200,000 1,266,900,000 1,276,900,000 1,280,100,000 1,297,200,000 1,300,200,000 1,286,600,000 1,251,800,000 1,215,400,000 1,180,700,000 1,156,800,000 1,130,900,000 1,102,500,000 1,101,500,000 1,089,500,000 1,079,800,000 1,055,300,000 1,041,000,000 1,521,800,000 1,511,800,000 1,491,200,000  
  total liabilities and stockholders’ equity1,039,000,000 1,107,800,000 1,154,200,000 1,656,200,000 1,657,800,000 1,661,300,000 1,692,400,000 1,724,900,000 1,666,700,000 1,734,900,000 1,786,900,000 1,775,200,000 1,752,800,000 1,766,500,000 1,594,600,000 1,597,900,000 1,683,300,000 1,648,800,000 1,672,800,000 1,799,100,000 1,755,900,000 1,763,700,000 1,799,600,000 1,807,700,000 1,783,400,000 1,834,000,000 1,833,400,000 1,844,500,000 1,917,400,000 2,202,900,000 2,195,900,000 2,148,900,000 2,124,900,000 2,086,400,000 2,071,800,000 2,095,000,000 2,112,000,000 2,019,700,000 2,000,200,000 2,006,300,000 2,485,500,000 2,536,400,000 2,527,600,000  
  common stock - 0.01 par value - authorized 300,000,000 shares, 46,236,444 outstanding as of march 31, 2025 and 45,962,627 outstanding as of december 31, 2024 500,000                                           
  assets held for sale   73,900,000 72,700,000 66,500,000 64,500,000 102,100,000 108,700,000                     650,400,000 632,500,000            2,600,000  
  liabilities held for sale   52,900,000 52,700,000 52,200,000 63,700,000 2,500,000 2,700,000                     37,900,000 33,900,000              
  common stock - 0.01 par value - authorized 300,000,000 shares, 45,962,627 outstanding at december 31, 2024 and 46,174,337 outstanding at december 31, 2023  500,000                                          
  common stock - 0.01 par value - authorized 300,000,000 shares, 45,954,931 outstanding as of september 30, 2024 and 46,174,337 outstanding as of december 31, 2023   500,000                                         
  common stock - 0.01 par value - authorized 300,000,000 shares, 45,913,043 outstanding as of june 30, 2024 and 46,174,337 outstanding as of december 31, 2023    500,000                                        
  common stock - 0.01 par value - authorized 300,000,000 shares, 46,066,997 outstanding as of march 31, 2024 and 46,174,337 outstanding as of december 31, 2023     500,000                                       
  common stock - 0.01 par value - authorized 300,000,000 shares, 46,174,337 outstanding at december 31, 2023 and 46,528,907 outstanding at december 31, 2022      500,000                                      
  common stock - 0.01 par value - authorized 300,000,000 shares, 46,425,157 outstanding as of september 30, 2023 and 46,528,907 outstanding as of december 31, 2022       500,000                                     
  common stock - 0.01 par value - authorized 300,000,000 shares, 46,832,847 outstanding as of june 30, 2023 and 46,528,907 outstanding as of december 31, 2022        500,000                                    
  common stock - 0.01 par value - authorized 300,000,000 shares, 46,660,199 outstanding as of march 31, 2023 and 46,528,907 outstanding as of december 31, 2022         500,000                                   
  common stock - 0.01 par value - authorized 300,000,000 shares, 46,528,907 outstanding at december 31, 2022 and 48,206,156 outstanding at december 31, 2021          500,000                                  
  common stock - 0.01 par value - authorized 300,000,000 shares, 46,495,519 outstanding as of september 30, 2022 and 48,206,156 outstanding as of december 31, 2021           500,000                                 
  common stock - 0.01 par value - authorized 300,000,000 shares, 46,849,951 outstanding as of june 30, 2022 and 48,206,156 outstanding as of december 31, 2021            500,000                                
  common stock - 0.01 par value - authorized 300,000,000 shares, 47,324,093 outstanding as of march 31, 2022 and 48,206,156 outstanding as of december 31, 2021             500,000                               
  income tax receivable              13,000,000 11,600,000 58,400,000 59,000,000 59,300,000                          
  common stock - 0.01 par value - authorized 300,000,000 shares, 48,206,156 outstanding at december 31, 2021 and 47,917,583 outstanding at december 31, 2020              500,000                              
  prepaid expenses and other current assets               19,700,000 18,800,000 18,300,000  21,200,000 20,200,000 23,700,000  29,900,000 26,200,000 47,100,000  52,400,000 48,400,000 15,800,000  20,000,000 19,700,000 16,700,000  31,100,000 25,000,000 26,800,000       
  common stock - 0.01 par value - authorized 300,000,000 shares, 48,128,749 outstanding as of september 30, 2021 and 47,917,583 outstanding as of december 31, 2020               500,000                             
  common stock - 0.01 par value - authorized 300,000,000 shares, 48,095,484 outstanding as of june 30, 2021 and 47,917,583 outstanding as of december 31, 2020                500,000                            
  common stock - 0.01 par value - authorized 300,000,000 shares, 48,059,819 outstanding as of march 31, 2021 and 47,917,583 outstanding as of december 31, 2020                 500,000                           
  operating lease right of use assets                  48,300,000    64,000,000                      
  current portion of operating lease obligation                  15,500,000    14,700,000                      
  operating lease obligation                  53,300,000    62,600,000                      
  common stock - 0.01 par value - authorized 300,000,000 shares, 47,917,583 outstanding at december 31, 2020 and 47,734,206 outstanding at december 31, 2019                  500,000                          
  common stock - 0.01 par value - authorized 300,000,000 shares, 47,833,115 outstanding as of september 30, 2020 and 47,734,206 outstanding as of december 31, 2019                   500,000                         
  common stock - 0.01 par value - authorized 300,000,000 shares, 47,802,185 outstanding as of june 30, 2020 and 47,734,206 outstanding as of december 31, 2019                    500,000                        
  common stock - 0.01 par value - authorized 300,000,000 shares, 47,755,911 outstanding as of march 31, 2020 and 47,734,206 outstanding as of december 31, 2019                     500,000                       
  common stock - 0.01 par value - authorized 300,000,000 shares, 47,734,206 outstanding at december 31, 2019 and 47,444,340 outstanding at december 31, 2018                      500,000                      
  common stock - 0.01 par value - authorized 300,000,000 shares, 47,719,954 outstanding as of september 30, 2019 and 47,444,340 outstanding as of december 31, 2018                       500,000                     
  common stock - 0.01 par value - authorized 300,000,000 shares, 47,653,527 outstanding as of june 30, 2019 and 47,444,340 outstanding as of december 31, 2018                        500,000                    
  common stock - 0.01 par value - authorized 300,000,000 shares, 47,504,680 outstanding as of march 31, 2019 and 47,444,340 outstanding as of december 31, 2018                         500,000                   
  common stock - 0.01 par value - authorized 300,000,000 shares, 47,444,340 outstanding at december 31, 2018 and 46,920,076 outstanding at december 31, 2017                          500,000                  
  common stock - 0.01 par value - authorized 300,000,000 shares, 47,426,996 outstanding as of september 30, 2018 and 46,920,076 outstanding as of december 31, 2017                           500,000                 
  restricted cash                            51,500,000                
  common stock - 0.01 par value - authorized 300,000,000 shares, 47,279,645 outstanding as of june 30, 2018 and 46,920,076 outstanding as of december 31, 2017                            500,000                
  common stock - 0.01 par value - authorized 300,000,000 shares, 47,014,536 outstanding as of march 31, 2018 and 46,920,076 outstanding as of december 31, 2017                             500,000               
  common stock - 0.01 par value - authorized 300,000,000 shares, 46,920,076 outstanding at december 31, 2017 and 46,681,798 outstanding at december 31, 2016                              500,000              
  common stock - 0.01 par value - authorized 300,000,000 shares, 46,835,044 outstanding as of september 30, 2017 and 46,681,798 outstanding as of december 31, 2016                               500,000             
  common stock - 0.01 par value - authorized 300,000,000 shares, 46,791,748 outstanding at june 30, 2017 and 46,681,798 outstanding at december 31, 2016                                500,000            
  common stock - 0.01 par value - authorized 300,000,000 shares, 46,695,242 outstanding at march 31, 2017 and 46,681,798 outstanding at december 31, 2016                                 500,000           
  common stock - 0.01 par value - authorized 300,000,000 shares, 46,681,798 outstanding at december 31, 2016 and 46,614,947 outstanding at december 31, 2015                                  500,000          
  common stock - 0.01 par value - authorized 300,000,000 shares, 46,674,183 outstanding at september 30, 2016 and 46,614,947 outstanding at december 31, 2015                                   500,000         
  common stock - 0.01 par value - authorized 300,000,000 shares, 46,670,129 outstanding at june 30, 2016 and 46,614,947 outstanding at december 31, 2015                                    500,000        
  common stock - 0.01 par value - authorized 300,000,000 shares, 46,614,947 outstanding at march 31, 2016 and december 31, 2015                                     500,000       
  current deferred income taxes                                          2,100,000  
  debt payable within one year                                         3,900,000 3,900,000 10,900,000 
  common stock - 0.01 par value - authorized 300,000,000 shares, 46,614,947 outstanding at december 31, 2015 and 46,535,951 outstanding at december 31, 2014                                      500,000      
  (accumulated deficit) retained earnings                                      -419,000,000 -433,600,000     
  current deferred income taxes and other current assets                                       25,500,000 14,800,000 17,400,000  50,800,000 
  common stock - 0.01 par value - authorized 300,000,000 shares, 46,613,982 outstanding as of september 30, 2015 and 46,535,951 as of december 31, 2014                                       500,000     
  common stock - 0.01 par value - authorized 300,000,000 shares, 46,605,790 outstanding as of june 30, 2015 and 46,535,951 as of december 31, 2014                                        500,000    
  retained earnings                                        36,900,000 29,000,000 7,300,000  
  common stock - 0.01 par value - authorized 300,000,000 shares, 46,535,951 outstanding as of march 31, 2015 and december 31, 2014                                         500,000   
  liabilities and equity                                            
  related party debt                                            
  preferred stock—0.01 par value—authorized 20,000,000 shares, none issued                                            
  common stock—0.01 par value—authorized 300,000,000 shares in 2014; 46,535,951 outstanding at december 31, 2014                                          500,000  
  kimberly-clark’s net investment                                            
  accumulated other comprehensive income                                          -19,100,000  
  liabilities and invested equity                                            
  long-term liabilities                                           92,500,000 
  invested equity                                            
  kimberly-clark's net investment                                           2,100,100,000 
  total invested equity                                           2,079,000,000 
  total liabilities and invested equity                                           2,449,400,000 
  operating activities                                            
  net income                                           29,500,000 
  depreciation and amortization                                           61,600,000 
  share-based compensation charged by kimberly-clark                                           5,100,000 
  benefit from losses on accounts receivable and inventories                                           100,000 
  deferred income taxes                                           -13,900,000 
  asset impairment                                           41,900,000 
  net incomees on asset dispositions                                           3,500,000 
  changes in operating working capital:                                            
  decrease (increase) in accounts receivable                                           10,900,000 
  increase in inventories                                           -9,100,000 
  increase in trade accounts payable                                           7,000,000 
  decrease in accrued expenses                                           -23,600,000 
  decrease in accrued income taxes                                           -3,900,000 
  other                                           -1,800,000 
  cash from operating activities                                           107,300,000 
  investing activities                                            
  capital spending                                           -60,400,000 
  cash outflows for acquisitions and investments                                            
  cash from investing activities                                           -60,400,000 
  financing activities                                            
  debt proceeds                                           1,900,000 
  debt repayments                                           -2,900,000 
  change in kimberly-clark's net investment                                           -34,800,000 
  cash from financing activities                                           -32,400,000 
  effect of exchange rate changes on cash and cash equivalents                                           -200,000 
  increase in cash and cash equivalents                                           14,300,000 
  cash and cash equivalents - beginning of period                                           44,100,000 
  cash and cash equivalents - end of period                                           58,400,000 

We provide you with 20 years of balance sheets for Avanos Medical stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Avanos Medical. Explore the full financial landscape of Avanos Medical stock with our expertly curated balance sheets.

The information provided in this report about Avanos Medical stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.